Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology Studies Ws#24 and #25
Levine, Barry S.
University of Illinois at Chicago, Chicago, IL, United States
Search 87 grants from Barry Levine
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
UCI International Research Training
Development of an H2O2-inactivated chikungunya virus vaccine
Cctg for Clinical Network for Ards Treatment
Serological Evaluation of Chlamydial Eye Infections
Minority High School Student Research Apprentice Program
Recently added grants:
Statewide Cancer Data
Biostatistics
Tissue Procurement Facility & Biospecimen
The Genome Aggregation Database (gnomAD)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN015352-002
Application #
3617533
Study Section
Project Start
1992-09-30
Project End
Budget Start
1992-09-30
Budget End
1994-09-29
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1992
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
NIH 1992
N01 CN
Preclinical Toxicology Studies Ws#24 and #25
Levine, Barry S. / University of Illinois at Chicago
NIH 1991
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
Publications
Crowell, James A; Page, John G; Levine, Barry S et al.
(2006)
Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450.
Toxicol Appl Pharmacol 211:115-23
Comments
Be the first to comment on Barry Levine's grant